VAIRA, BERARDINO
 Distribuzione geografica
Continente #
EU - Europa 14.804
NA - Nord America 14.472
AS - Asia 12.979
SA - Sud America 1.124
Continente sconosciuto - Info sul continente non disponibili 785
AF - Africa 409
OC - Oceania 14
Totale 44.587
Nazione #
US - Stati Uniti d'America 14.179
IT - Italia 8.578
SG - Singapore 4.090
VN - Vietnam 3.245
CN - Cina 2.922
GB - Regno Unito 1.583
HK - Hong Kong 1.095
DE - Germania 873
BR - Brasile 868
SE - Svezia 660
NL - Olanda 591
FR - Francia 538
IN - India 454
UA - Ucraina 443
RU - Federazione Russa 430
IE - Irlanda 247
BD - Bangladesh 202
JP - Giappone 188
KR - Corea 170
FI - Finlandia 166
ZA - Sudafrica 161
CA - Canada 145
BG - Bulgaria 121
CH - Svizzera 118
EE - Estonia 112
AR - Argentina 100
JO - Giordania 96
ID - Indonesia 85
ES - Italia 80
SC - Seychelles 67
TH - Thailandia 64
MX - Messico 63
PH - Filippine 61
IQ - Iraq 54
CI - Costa d'Avorio 50
PL - Polonia 45
AT - Austria 42
TR - Turchia 41
EC - Ecuador 39
BE - Belgio 38
PK - Pakistan 37
TW - Taiwan 33
CO - Colombia 28
AL - Albania 27
TG - Togo 27
PY - Paraguay 26
GR - Grecia 24
SA - Arabia Saudita 24
MY - Malesia 19
PE - Perù 19
MA - Marocco 18
DO - Repubblica Dominicana 17
RO - Romania 17
VE - Venezuela 17
EU - Europa 16
EG - Egitto 15
JM - Giamaica 15
UZ - Uzbekistan 14
CL - Cile 13
KE - Kenya 13
LB - Libano 13
LT - Lituania 13
GT - Guatemala 11
IR - Iran 11
AU - Australia 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
LY - Libia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
CR - Costa Rica 7
DZ - Algeria 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
ET - Etiopia 6
HR - Croazia 6
NG - Nigeria 6
NP - Nepal 6
PT - Portogallo 6
AZ - Azerbaigian 5
BO - Bolivia 5
DK - Danimarca 5
HN - Honduras 5
KZ - Kazakistan 5
NI - Nicaragua 5
GA - Gabon 4
NO - Norvegia 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BS - Bahamas 3
LU - Lussemburgo 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 43.764
Città #
Singapore 2.503
Southend 1.352
San Jose 1.226
Ashburn 1.133
Hong Kong 1.053
Santa Clara 972
Milan 824
Fairfield 815
Ho Chi Minh City 800
Chandler 674
Hanoi 658
Rome 638
Boardman 568
Council Bluffs 467
Woodbridge 418
Hefei 404
Wilmington 403
Beijing 399
Bologna 399
Seattle 386
Houston 368
Princeton 367
Naples 345
Jacksonville 291
Cambridge 285
Ann Arbor 249
Dong Ket 246
Dublin 246
Los Angeles 220
New York 197
Lauterbourg 195
Turin 184
Padova 179
Tokyo 164
Nanjing 160
Bari 150
Westminster 149
Seoul 141
Helsinki 138
Florence 126
Buffalo 121
Sofia 119
Berlin 114
Da Nang 104
Dallas 103
Palermo 102
Amman 94
Haiphong 93
São Paulo 86
Shanghai 84
Verona 84
Jinan 82
Guangzhou 74
Catania 73
Chicago 73
Saint Petersburg 69
Modena 67
Shenyang 66
Brescia 63
Orem 63
Redondo Beach 60
San Diego 60
Tappahannock 60
Frankfurt am Main 58
Genoa 57
Mülheim 57
Parma 56
San Francisco 56
Nanchang 55
Phoenix 55
Atlanta 53
Changsha 52
Abidjan 50
Frattamaggiore 50
Tianjin 48
Reggio Emilia 47
Biên Hòa 41
Pescara 41
Redmond 41
Zhengzhou 41
Hải Dương 40
Trieste 40
Des Moines 39
Hangzhou 39
Falkenstein 38
Mexico City 37
Hebei 36
Can Tho 35
Dearborn 35
Denver 35
Rimini 35
Venice 35
Yubileyny 35
Warsaw 34
Cagliari 33
Mahé 33
Montreal 33
Thái Nguyên 33
Bengaluru 32
Brussels 32
Totale 23.973
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 6.216
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 1.126
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 612
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 610
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 393
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 290
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 285
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 272
In vivo dissolution of levothyroxine soft gel capsules 251
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 241
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 233
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 232
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 226
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 218
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 213
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 210
Diagnosi non invasiva e terapia per Helicobacter Pylori 209
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 206
H. pylori antibiotic resistance and 13C urea breath test values. 204
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 203
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 203
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 202
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 201
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 198
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 197
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 197
13C-urea breath test values and Helicobacter pylori eradication 196
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 195
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 194
Response to Dr Osato and Graham 192
Gastroesophageal Reflux Disease and Barrett’s Esophagus 191
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 186
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 185
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 185
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 182
Diagnosi dell’infezione da Helicobacter pylori 181
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 180
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 176
Nuove terapie per curare l’infezione da Helicobacter pylori 175
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 175
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 174
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 172
Therapy for H. pylori: Current concepts 172
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 171
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 170
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 170
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 170
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 167
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 166
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 165
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 165
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 164
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 164
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 163
Helicobacter pylori: current status and future prospects 161
Peptic ulcer and Helicobacter pylori. 161
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 160
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 160
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 160
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 159
Treatment of Helciobacter pylori infection 2014 159
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 159
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 159
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 159
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 158
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 157
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 154
Probiotici ricombinanti e loro potenziale sulla salute umana 153
An Atlas of Investigation and Management: HELICOBACTER PYLORI 152
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 152
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 150
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 150
Diagnosi dell'infezione da Helicobacter pylori 150
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 147
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 147
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 147
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 146
Recombinant probiotics and their potential in human health 145
Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients 144
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 144
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 143
Helicobacter pylori and functional dyspepsia: an unsolved issue? 142
Treatment of Helicobacter Pylori in Latin America 141
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 141
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 141
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 140
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 140
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 140
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 140
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 139
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 138
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 137
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 137
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 134
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 134
Letter: years of life that could be saved by preventing HCC 134
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients 134
The stool antigen test for detection of Helicobacter pylori after eradication therapy 133
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 133
Glaucoma and Helicobacter pylori: Eyes wide shut? 133
Totale 25.341
Categoria #
all - tutte 123.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.627 0 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.401 482 336 191 291 187 292 170 130 145 361 429 387
2024/20259.979 555 1.065 607 672 1.984 694 963 631 496 541 355 1.416
2025/202615.494 1.439 1.204 1.532 1.254 1.639 920 1.171 1.123 2.595 1.234 711 672
2026/20272.417 1.484 933 0 0 0 0 0 0 0 0 0 0
Totale 44.587